Biogen Pharmachem Industries Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 21.202 million. Net income was INR 6.193 million compared to net loss of INR 0.87 million a year ago. Basic earnings per share from continuing operations was INR 0.01. For the full year, total revenue was INR 0.145 million. Net loss was INR 16.032 million compared to INR 1.167 million a year ago. Basic loss per share from continuing operations was INR 0.02.